AavantiBio lands manufacturing partner in Friedreich's Ataxia program; NC Research Triangle lands another CDMO
AavantiBio and Resilience have announced a collaboration to manufacture a pipeline of therapies, including AavantiBio’s Friedreich’s Ataxia program, the company announced Thursday.
The adeno-associated viral …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.